skip navigation nih record
Vol. LXII, No. 15
July 23, 2010
cover

previous story

next story



NCI, U. of Maryland Team Up To Fight Cancer

University of Maryland president Dr. C.D. Mote, Jr. (c) looks on as Dr. Robert Wiltrout (l), director of the NCI Center for Cancer Research, and Dr. Melvin Bernstein (r), vice president for research at Maryland, sign an agreement establishing the Collaborative Research and Graduate Partnership Program in Cancer Technology.

University of Maryland president Dr. C.D. Mote, Jr. (c) looks on as Dr. Robert Wiltrout (l), director of the NCI Center for Cancer Research, and Dr. Melvin Bernstein (r), vice president for research at Maryland, sign an agreement establishing the Collaborative Research and Graduate Partnership Program in Cancer Technology.

Hoping to capitalize on the idea that solutions to fundamental questions in one field are facilitated by approaches and input from experts in another, Dr. Robert Wiltrout, director of the Center for Cancer Research, and University of Maryland vice president for research Dr. Melvin Bernstein signed a formal memorandum of understanding recently at the College Park campus.

Maryland graduate students had already been working in NCI laboratories for several years. Research presented by these students in a 2007 poster session convinced administrators that an official program would benefit both institutions.

The agreement between CCR and the departments of physics, mathematics and the Institute for Physical Sciences and Technology establishes the Collaborative Research and Graduate Partnership Program in Cancer Technology. This will allow qualified Maryland graduate students to conduct research under the joint supervision of CCR and university faculty. A series of lectures, workshops and meetings will accompany the program.

Additionally, the understanding facilitates collaborations among cancer researchers, physical scientists, mathematicians and engineers on the two campuses. The goal is to bring their various expertises to bear on the complex issues of cancer biology.

“We are very enthusiastic about this partnership with the University of Maryland,” said Wiltrout. “I believe it will make both institutions stronger and ultimately advance cancer research for the benefit of patients. We can accomplish more by working in interdisciplinary teams.”

More information on the partnership and announcements of upcoming events can be found at http://cancertechnology.umd.edu

back to top of page